Jump to content

Erysodienone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by FoCuSandLeArN (talk | contribs) at 21:23, 26 May 2015 (major copy edit). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.


Structure of erysodienone and its proposed biosynthetic pathway
Biomimetic synthesis of erysodienone.

Erysodienone is a key precursor in the biosynthesis of many Erythrina-produced alkaloids.[1] Early work was done by Derek Barton and co-workers to illustrate the biosynthetic pathways towards erythrina alkaloids.[2][3][4] It was demonstrated that erysodienone could be synthesized from simple starting materials by a similar approach as its biosynthetic pathway, which lead to the development of the biomimetic synthesis of erysodienone.[5]

Synthesis

The biosynthesis of erysodienone involves a key step of oxidative phenol coupling. Starting with S-norprotosinomenine precursor A, cyclization via oxidative phenol coupling forms intermediate B, which in turn can be rearranged to form intermediate C. Hydrogenation of C forms the diphenoquinone intermediate E. An intramolecular Michael addition reaction converts E to the final product, erysodienone.[6]

A biomimetic synthesis route for erysodienone was developed based on a similar oxidative phenol coupling mechanism. Barton and co-workers[7] found that treating bisphenolethylamine precursor F with oxidants such as K3Fe(CN)6 initiated oxidative phenol coupling to form the 9-membered ring structure in intermediate D that itself undergo a Michael addition to give erysodienone.[8]

References

  1. ^ Rahman, Mohammed Z., et al. "Phytochemical and biological investigations of Erythrina variegata." Saudi Pharmaceutical Journal 15.2 (2007): 140.
  2. ^ Barton, D. H. R.; Boar, R. B.; Widdowson, D. A. J. Chem. Soc. C 1970, 1213.
  3. ^ Barton, D. H. R.; Potter, C. J.; Widdowson, D. A. J. Chem. Soc. Perkin. Trans. 1974, 1346.
  4. ^ Barton, D. H. R.; James, R.; Kirby, G. W.; Turner, D. W.; Widdowson, D. A. J. Chem. Soc. C 1968, 1529.
  5. ^ Herbert, R. B. (1985). "The Biosynthesis of Isoquinoline Alkaloids": 213–228. doi:10.1007/978-3-642-70128-3_14. ISSN 0172-6625. {{cite journal}}: Cite journal requires |journal= (help)
  6. ^ Maier UH, Rödl W, Deus-Neumann B, Zenk MH (1999). "Biosynthesis of Erythrina alkaloids in Erythrina crista-galli". Phytochemistry. 52 (3): 373–82. PMID 10501023.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Barton, D. H. R.; Boar, R. B.; Widdowson, D. A. J. Chem. Soc. C 1970, 1208
  8. ^ M. F. Grundon (1 January 1979). The Alkaloids:. Royal Society of Chemistry. pp. 16–. ISBN 978-0-85186-660-4.

Further Reading

  • Soto-Hernández, R. Marcos, et al. "Erythrina, a Potential Source of Chemicals from the Neotropics." Bioactive Compounds in Phytomedicine (2011): 163.
  • Chou, Chun Tzer, and John S. Swenton. "A convergent strategy for synthesis of Erythrina alkaloids." Journal of the American Chemical Society 109.22 (1987): 6898-6899.
  • Castedo, Luis, and Domingo Dominguez. "Dibenzazonine Alkaloids." The Alkaloids: Chemistry and Pharmacology 35 (1989): 177-214.